GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Heron Therapeutics Inc. (HRTX) [hlAlert]

Rating:
Mkt Outperform
HRTX
up 178.33 %

Heron Therapeutics Inc. (HRTX) rated Mkt Outperform with price target $20 by JMP Securities

Posted on: Thursday,  Mar 6, 2014  8:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform Heron Therapeutics Inc. (NASDAQ: HRTX) on 03/06/2014. Previously JMP Securities rated Mkt Outperform Heron Therapeutics Inc. (NASDAQ: HRTX)
on 06/13/2012., when the stock price was $12.00. Since then, Heron Therapeutics Inc. has gained 178.33% as of 01/19/2016's recent price of $33.40.
If you would have followed the previous JMP Securities's recommendation on HRTX, you would have gained 178.33% of your investment in 1315 days.

A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company focused on developing pharmaceutical products using its Biochronomer polymer-based drug delivery technology. The Company?s primary focus is on its lead product candidate, APF530, which completed a pivotal Phase III clinical trial for the prevention of chemotherapy-induced nausea and vomiting (CINV) during the year ended December 31, 2008. APF530 is designed to prevent CINV for at least five days and contains granisetron, a drug approved for the prevention of CINV. In addition to its lead drug candidate, A.P. Pharma has a pipeline of other product candidates that use its Biochronomer technology. One of these, APF112, incorporates the local anesthetic, mepivacaine. It is designed to provide up to 36 hours of post-surgical pain relief and to minimize the use of morphine-like drugs, or opiates, which are used in post-surgical pain management.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/6/2014 8:25 AM Buy
None
13.96 20.00
as of 10/17/2014
1 Week up  5.23 %
1 Month down  -18.77 %
3 Months down  -15.74 %
1 YTD down  -16.40 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/13/2012 11:25 AM Buy
None
12.00 60.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy